Company / CapEx per Share
enGene Holdings Inc. CapEx per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.03
FY2025
5-year range
$0.02 / $0.46
FY2022-FY2025
Trend
+18.7%
vs FY2024
Sector context
#90 of 191
Health Care
What the data says
At $0.03, enGene Holdings Inc.'s capex per share ranks #90 of 191 in the Health Care sector. Declined from $0.46 to $0.03 over the past 2 years.
Based on SEC 10-K filings.
0.03 in FY2025 with a 3-year CAGR of -50.1%.
Declined from $0.46 to $0.03 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -50.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 191 in Health CareTop 47% of 191This company $0.03 Sector average $4.05
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 18.7% year-over-year.
- Ranks #90 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | +18.7% |
| FY2024 | $0.02 | -94.7% |
| FY2023 | $0.46 | +96.6% |
| FY2022 | $0.23 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026